17-21 June, Gothenburg
1-P | Utilisation of LEAN Startup Methodology for the Identification, Development, and Pilot of Novel Services that can be Provided to Hospital Transfusion Laboratories. | matthew hazell | Received |
3-P | Characterizing the Transfusion Continuum in a Low-Resource Referral Hospital in Kenya: A Qualitative Study of Emergency Transfusion Measures | Cindy Makanga | Received |
13-P | ONBOARDING THE WOG WORKFLOW MANAGEMENT SYSTEM FOR A ROBUST OCCURRENCE REPORTING SYSTEM | Thilakavathi J | Received |
16-P | Evaluation of a new-generation nucleic acid testing (NAT) middleware to improve process efficiency through full real-time monitoring of the NAT instrumentation | Fatima Lopez | Received |
24-P | Developing Immersive Virtual Reality for Transfusion Laboratory Training | Laura Eastwood | Received |
25-P | Pilot of an Immersive Virtual Reality Red Blood Cell Crossmatching Training Package | Laura Eastwood | Received |
31-P | Collaboration & communication: key elements of implementing state-wide change to reduce O RhD negative red blood cell use | Linley Bielby | Received |
35-P | Plasma self-sufficiency: insights for the success of the action plan | Pilar Córdoba | Received |
36-P | INCREASING EFFICIENCY AND EFFECTIVENESS BY MODIFYING BLOOD BANK CROSS MATCHING POLICY | Hanna morani | Received |
42-P | Optimising WB component supply A Monte Carlo simulation model | Josephine McCullagh | Received |
43-P | Insuring blood supply and financial sustainability with a new university-based blood bank | Marcia Cardoso | Received |
44-P | 6-month experiences with platelet inventory management by RFID Smart Storage Solution | Nicolas de Valensart | Received |
46-P | Analysis of appropriate indications and outcomes of patients receiving plasma-reduced platelet transfusions | Hartirathpal Kaur | Received |
69-P | Changes in demography and infectious disease prevalence in US blood donors during the COVID-19 pandemic on behalf of the US TTIMS Program | Galen Conti | Received |
71-P | Post Donation Call Back in Singapore: A Review of Cases from 2020-2022 | RAMIR ALCANTARA | Received |
79-P | Donation drivers and brakes: a qualitative approach to the human condition | Pilar Córdoba | Received |
80-P | Impact of WhatsApp on donor invitations | Pilar Córdoba | Received |
81-P | Connecting with donors: empathy maps | Pilar Córdoba | Received |
87-P | Platelet transfusion to patients with CD36 isoantibody | Brigitte Flesch | Received |
89-P | Removal of UK-residence deferral for variant Creutzfeldt-Jakob disease: impact on donor sufficiency in Australia | Veronica Hoad | Received |
93-P | How to Ensure a Memorable Donation Experience | Pilar Córdoba | Received |
96-P | Influencing first time donors to return. | Simon Davies | Received |
98-P | Ferritin testing as a risk mitigation strategy to protect frequent whole blood donors at Health Sciences Authority (HSA), Singapore | Wooi Seong Kam | Received |
102-P | Blood donors profile in a Costa Rican regional hospital from 2015 to 2019 | Wendy Ordóñez Varela | Received |
115-P | Simulated effects of ferritin screening on hs-CRP in recruited donors | Esa Turkulainen | Received |
130-P | CD4 lymphopenia among French cytapheresis donors | Pascale Richard | Received |
138-P | PREDICTING WHO IS AT RISK OF EXPERIENCING VASOVAGAL REACTIONS USING PRE-DONATION ANTICIPATED EMOTIONAL STATES. | Judita Rudokaite | Received |
149-P | DEHT-PAGGSM blood bag devices do not affect the quality results on the processing Multicentric and collaborative study | Anais Lotens | Received |
156-P | DONOR FACTORS AFFECTING PLATELET RECOVERY FROM WHOLE BLOOD DONATIONS AND BEST WHOLE BLOOD DONORS FOR PLATELETS | Ana Pérez | Received |
163-P | Characterization of residual cell populations in leukoreduction system (LRS) disposable sets following apheresis platelet collections in plasma versus PAS | Susanne Marschner | Received |
165-P | How to minimize residual cells in specific blood components. Optimizing an automated processing system | MARTINEZ NURIA | Received |
180-P | Evaluation of thawing Fresh Frozen Plasma at 37oC and 45oC | Josephine McCullagh | Received |
181-P | Qualification of a residual white blood cell counter based on fluorescent microscopy | Anais Lotens | Received |
182-P | EBA Working Group, European Quality Control Proficiency Testing Scheme | Nadine Marpaux | Received |
183-P | Comparison between fluorescent microscopy and cytometry for residual white blood cell counting in blood components | Anais Lotens | Received |
191-P | Patient reported outcomes of Serum Eye Drops (SED) manufactured from Australian blood donations and packaged using MEISE vials | Phillip Mondy | Received |
205-P | INITIAL EXPERIENCE OF SWITCHING PATHOGEN INACTIVATION SYSTEM WITH EXTENDED PLATELET SHELF LIFE | Nicolas Malvaux | Received |
207-P | PATHOGEN REDUCED PLASMAS FROM MAXI-POOLS COMBINED WITH FAST THAWING FOR USE IN EMERGENCY SITUATIONS | Marja-Kaisa Auvinen | Received |
217-P | Granulocyte pooling: an alternative to the classical collection method from apheresis? | MARTINEZ NURIA | Received |
224-P | Prevalence of acute Hepatitis E virus infections in Swiss Blood Donations 2018-2020 | Peter Gowland | Received |
225-P | 21 years experience in NAT screening of blood donors: analyisis of data recorded at ASST-Spedali Civili, Brescia (Italy) | Susanna Bresciani | Received |
228-P | Global Nucleic Acid Amplification Testing (NAT) Use and Confirmatory Testing Approaches in Blood Donor Screening | Helen Faddy | Received |
230-P | Seroprevalence of transfusion-transmissible infections among blood donors in Nigeria: a retrospective analysis of blood donor data in the six geo-political regions. | Adaeze Oreh | Received |
231-P | Comparison of two automated NAT systems for HIV, HBV, and HCV | Jean Stanley | Received |
235-P | Improved efficiency using sequential screening assays for Treponema pallidum (syphilis) in blood donations | Anthea Cheng | Received |
254-P | Risk factors of hepatitis C infection in Repeated Donors Vary Geographically: A nested case-control study | Ching-Mei Yu | Received |
257-P | Evaluation of HIV immunoassays for blood donor screening using nationwide real-world data | Guillermo Andres Orjuela-Falla | Received |
263-P | Comparable detection of bacterial contamination in apheresis platelet concentrates suspended in plasma or platelet additive solution E with an automated culture method | Sandra Ramirez-Arcos | Received |
265-P | DETECTION OF PLASMODIUM IN SPECIMENS FROM HEALTHY ASYMPTOMATIC INDIVIDUALS IN NIGERIA BY COBAS MALARIA | XIAOMEI ZHU | Received |
269-P | Anti-SARS-CoV-2 antibody development during the COVID-19 pandemic in Swiss blood donors | Peter Gowland | Received |
274-P | Development of a Mayaro and Yellow fever virus duplex real-time RT-PCR assay for high-throughput testing | Carlo Fischer | Received |
282-P | TRANSMISSION OF VARIANT CREUTZFELDT-JAKOB DISEASE THROUGH BLOOD TRANSFUSION AND PLASMA-DERIVED PRODUCTS: A NARRATIVE REVIEW OF OBSERVED AND MODELIZED RISKS | Lewin Antoine | Received |
284-P | Evaluation of a novel monoclonal anti-Vel phenotyping reagent. | Gareth Nottage | Received |
287-P | IMPLEMENTATION OF ERYTRA AUTOMATED ANALYSER FOR BLOOD GROUP TYPING IN A BLOOD DONOR SETTING: EXPERIENCE AND FIRST RESULTS | Caroline Tinguely | Received |
288-P | An Improved Approach to Detecting the Variant RhD - DVI in Donors | Tony Casina | Received |
300-P | Paroxysmal cold hemoglobinuria in a pediatric patient with concurrent warm and cold autoantibodies | Keenan Hogan | Received |
315-P | MULTIDISCIPLINAR MANAGEMENT AND OUTCOME OF A PREGNANT WOMEN WITH H DEFICIENT RED CELLS (BOMBAY PHENOTYPE) | Angel Luis Pajares Herraiz | Received |
316-P | Five Cases of Piperacillin-Induced Immune Haemolytic Anaemia | Claudia Ruhland | Received |
328-P | IMPLEMENTATION OF AUTOMATED SEROLOGICAL CROSSMATCH PROCESS FOR PRBC TRANSFUSION IN A HOSPITAL BLOOD TRANSFUSION SERVICE | Niythiya Mohan | Received |
331-P | Performance evaluation of a new Direct Coombs card based on column agglutination system | Laziza Amniai | Received |
338-P | CEPHALOSPORINS INDUCED HEMOLYTIC ANEMIA: A CASE STUDY | Graa Almeida | Received |
347-P | Identifying RHCE variants in Flanders (Belgium) and implications on regional transfusion policy | Vicky Van Sandt | Received |
351-P | BLOOD GROUP GENOTYPING IN DONORS OF AFRICAN DESCENT | Rahel Kräuchi | Received |
355-P | A NOVEL RHD ALLELE IN A CAUCASIAN BLOOD DONOR | Laziza Amniai | Received |
356-P | Characterization of three novel RHCE mutations inducing aberrant C expression | Sarah Petermann | Received |
366-P | A novel missense variant c.1AT on the ABO*B.01 allele associated with a Bw phenotype | Ji Yeong Seo | Received |
367-P | A novel frameshift mutation in the XK gene in a Finnish patient with McLeod syndrome | Susanna Sainio | Received |
369-P | Diagnosis of variant D phenotype (DIII type 7) in a patient with anti-D alloantibody | Ignacio Pereira | Received |
370-P | Two novel alleles harboring a deletion in the KEL and RH blood group system | Christine Henny | Received |
402-P | A National Comparison of the Uncertainty of Measurement in different D Positive Red Cell Volumes by Flow Cytometry | Vera Rosa | Received |
406-P | ANTI-U IN PREGNANCY AND HAEMOLYTIC DISEASE OF THE FETUS AND NEWBORN: A CASE SERIES AND LITERATURE REVIEW | Harshita Rajasekariah | Received |
409-P | Follow-up with titration in pregnancy for suspected allo-anti-HPA5b FNAIT: case study | Susanna Bresciani | Received |
445-P | Rethinking and personalising the transfusion pathway in myelodysplastic syndromes (MDS): a novel trial of weekly matched red cell transfusion to improve quality of life | Allison Mo | Received |
446-P | Does treatment of anaemia improve quality of life or physical function for patients with myelodysplastic syndromes (MDS): a systematic review | Allison Mo | Received |
462-P | Platelet transfusion and Rh-D alloimmunization, is prophylaxis still required? | Nour AlMozain | Received |
471-P | Development of an immunodeficient mouse model of massive haemorrhage with acute thrombocytopaenia to validate the haemostatic effect of human platelet transfusion | Keita Uchiyama | Received |
472-P | AN APPROACH TO EMERGENCY TRANSFUSION IN TRAUMA AND HAEMORRHAGE: ANALYSIS OF URGENT BLOOD SUPPLY CASES IN SLIM RIVER HOSPITAL, MALAYSIA | Irni MOHD YASIN | Received |
479-P | Evaluation of Clinical Outcomes and Healthcare Resource Utilization in Patients with Sickle Cell Disease Before and After Suspected Alloimmunization: Real-world Evidence from 2011 to 2021 | CRISTINA COLL-ORTEGA | Received |
490-P | Factors Associated with Mortality in Transfusion Associated Circulatory Overload | Mark John McVey | Received |
511-P | Screening for Iron Deficiency among Pregnant Women | Wejdan AlQurashi | Received |
519-P | Autologous Tansfusion REquirements in bone MArrow harvest: preliminary results of the ATREMA study. | Luciana Teofili | Received |
537-P | Reducing the DMSO concentration in the cryopreservation mixture from 10 to 5 improves cell viability, results of a validation study. | Nour AlMozain | Received |
542-P | Determination of genetic markers of alloimmunization: Association between the presence of alloantibodies against erythrocyte antigens and specific HLA class II alleles. | María Antonieta Nuñez | Received |
17-21 June, Gothenburg
Digital Object Identifier. Official code used to identify documents published on internet; similar to ISBN for books. You may use this code to reference your poster in future scientific publications or CVs. It can be found from anywhere in the world. To find the poster page, log onto www.medra.org and enter the DOI, or enter in your internet browser https://dx.doi.org/ followed by the DOI string asigned to your congress. |
||||
|